alpha-aminopyridine and Epstein-Barr Virus Infections
alpha-aminopyridine has been researched along with Epstein-Barr Virus Infections in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Fu, HR; Gao, QQ; Huang, H; Shi, JM; Tan, YM; Yang, TT; Zhao, YM | 1 |
| Esquivel, CO; Hatton, O; Krams, SM; Lambert, SL; Martinez, OM; Natkunam, Y; Phillips, LK; Vaysberg, M | 1 |
Other Studies
2 other study(ies) available for alpha-aminopyridine and Epstein-Barr Virus Infections
| Article | Year |
|---|---|
Successful treatment of early onset Epstein-Barr virus-negative T-cell lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation with histone deacetylase inhibitor chidamide.
Topics: Aminopyridines; Benzamides; Epstein-Barr Virus Infections; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Histone Deacetylase Inhibitors; Humans; Lymphoproliferative Disorders; T-Lymphocytes | 2021 |
Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder.
Topics: Aminopyridines; Animals; Apoptosis; B-Lymphocytes; Cell Cycle; Cell Line, Tumor; Enzyme Activation; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Intracellular Signaling Peptides and Proteins; Lymph Nodes; Lymphoma, B-Cell; Lymphoproliferative Disorders; Male; Mice; Mice, Inbred NOD; Mice, SCID; Morpholines; Oxazines; Phosphatidylinositol 3-Kinases; Postoperative Complications; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; Signal Transduction; Syk Kinase; Transplantation, Heterologous | 2013 |